Board

Claes Holmberg

Claes Holmberg, born 1954, Master of Science degree in Engineering Physics and a PhD in theoretical physics. Holmberg has experience as VP of Nobel Pharma AB / Nobel Biocare AB and other companies and as CEO of Medi Team AB / Biolin AB and Biolight AB. Holmberg has also been the Chairman and a director of a number of medical device companies and in national interdisciplinary research programs. Holmberg has been involved in PExA’s business development since 2012, two years before incorporation.

Anna-Carin Olin

Anna Carin Olin, MD, PhD, born 1960, is a researcher and inventor of PExA and is today the company’s research director. Olin has medical training and is a consultant and Professor of Occupational and Environmental medicine, directing research at the Sahlgrenska Academy’s Unit for Occupational and Environmental Medicine, AMM, at the University of Gothenburg. Olin has been involved in PExA’s business development since the 2000s.

Björn Dahlöf

Björn Dahlöf, born 1953, MD, PhD, FESC, FACC, is a licensed physician, associate professor with specialist training in general internal medicine and almost 40 years of experience in hospital work. Extensive research in cardiovascular medicine with over 400 scientific publications. Advisor to most major pharma companies within pharmaceutical development and strategy. Participated in and started several companies in Life Science. Currently CMO at Cereno Scientific, which is developing future thrombotic drugs and therapies for rare diseases through epigenetic modulation. Board member since 2021.

Roy Jonebrant

Roy Jonebrant, born 1956, is a member of the board of PExA since 2018. Jonebrant is also CEO of GOKAP Invest AB and has many years of experience as CFO in a number of Swedish development companies, such as MediTeam AB, Biolin AB, Biolight AB and as Vice President / CFO in Pilum AB (publ). He also works as a financial consultant in his own company on behalf of a number of listed companies. Jonebrant has extensive experience from various board assignments in listed and unlisted companies.

Martin Malmström

Martin Malmström, born 1975, is a business-oriented and marketing professional with a Master of Business Administration degree. He has extensive global experience from the pharma & medtech industry, but also Labtech for more than 20 years. Martin Malmström has held business positions in prominent companies, including Sanofi and Mölnlycke Health Care. His current position is CCO at Biolin Scientific, responsible for Sales, Marketing and Service. Board member since 2023.

Åsa Wheelock